DocuSign (NASDAQ:DOCU) Announces Quarterly Earnings Results

DocuSign (NASDAQ:DOCUGet Free Report) posted its earnings results on Thursday. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02, Briefing.com reports. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million during the quarter, compared to analysts’ expectations of $760.94 million. During the same quarter in the prior year, the firm earned $0.76 EPS. DocuSign’s quarterly revenue was up 9.0% on a year-over-year basis. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.

DocuSign Stock Up 14.8 %

DOCU stock opened at $85.76 on Friday. DocuSign has a 12-month low of $48.70 and a 12-month high of $107.86. The company has a market cap of $17.33 billion, a price-to-earnings ratio of 17.68, a PEG ratio of 6.94 and a beta of 1.02. The company has a 50 day moving average of $87.97 and a two-hundred day moving average of $79.22.

Insiders Place Their Bets

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the transaction, the chief financial officer now owns 77,851 shares in the company, valued at $6,765,251.90. This trade represents a 9.32 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction on Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at $13,712,088.78. This trade represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 104,422 shares of company stock worth $9,665,394 in the last quarter. 1.66% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on DOCU shares. Bank of America decreased their target price on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a research report on Friday. Jefferies Financial Group increased their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Piper Sandler increased their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and increased their price objective for the company from $70.00 to $75.00 in a report on Monday, March 10th. Finally, UBS Group decreased their price objective on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a report on Friday. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $95.58.

View Our Latest Research Report on DocuSign

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Earnings History for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.